Navigation Links
Multiple Data Presentations on Syndax Pharmaceutical's Entinostat at Upcoming Scientific Conferences
Date:12/1/2011

WALTHAM, Mass., Dec. 1, 2011 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announced today that multiple data presentations from phase 2 clinical trials with entinostat in combination and as a single agent will be made at upcoming scientific conferences. 

San Antonio Breast Cancer Symposium
Data from ENCORE 301, a multicenter, randomized, double-blind, placebo-controlled, phase 2 study of exemestane with and without entinostat in 130 postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer, will be presented in a poster discussion at the San Antonio Breast Cancer Symposium taking place December 6 to 10 in San Antonio, Texas.  Denise A. Yardley, MD, breast program leader, senior investigator at the Sarah Cannon Research Institute and principal investigator of the study, will present the data which will include an update on overall survival. 

Presentation Date/Time: Wednesday, December 7 from 5:00 PM - 7:00 PM
Poster Title: Entinostat, a Novel Histone Deacetylase Inhibitor, Added to Exemestane Improves PFS in Advanced Breast Cancer in a Randomized, Phase II, Double-Blind Study
Session: POSTER DISCUSSION I: Endocrine Resistance
Abstract Number: PD01-04
Location: Ballroom A

American Society of Hematology Annual Meeting and Exposition
Data from ENGAGE 501, a multicenter, phase 2 study entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, in patients with relapsed or refractory Hodgkin's lymphoma will be presented at the American Society of Hematology Annual Meeting and Exposition in San Diego on December 11 from 6:00 PM to 8:00
'/>"/>

SOURCE Syndax Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Combination Study of MM-121 and Multiple Anticancer Therapies in Patients with Advanced Solid Tumors
2. Multiple Programs from Merrimack Pharmaceuticals Pipeline to be Presented at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
3. Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research
4. Pharmacyclics Reports Fiscal 2012 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 53rd American Society of Hematology Annual Meeting
5. Biogen-Idecs BG-12 Shines At the Top of the Charts in the Treatment of Relapsing-Remitting Multiple Sclerosis
6. Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth
7. Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010
8. DxTerity and Caliper Life Sciences Partner to Deliver NEAT® Multiplex Assays on Calipers LabChip® Dx Platform
9. Nutra Pharma Receives Patent for Their Multiple Sclerosis Drug
10. S1P1 Agonists are Currently Indicated For Treatment of Multiple Sclerosis
11. Phase 1 / 2 Clinical Trial Results of KRX-0401 (Perifosine) Plus Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma Published in the Journal of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 2015 Vectorious Medical Technologies, ... system for patients suffering from congestive heart failure ... $5 million financing round. Investors in the round ... by Yehuda Zisapel and Prof. Nava Zisapel ... Muntzer and others; and the U.S.-based Global Cardiovascular ...
(Date:2/26/2015)... Feb. 26, 2015  CSSi, ( www.CSSiEnroll.com ) ... clinical research industry, is pleased to announce the ... a Project Manager, adding significant value and expertise ... http://photos.prnewswire.com/prnh/20150225/177750 Karen is ... ability to successfully lead the navigation of the ...
(Date:2/26/2015)... Editor Note: For more ... Investor-Edge has initiated coverage on the following ... Teva Pharmaceutical Industries Ltd (NYSE: TEVA ), ... Inc. (NYSE: AGN ), and Depomed Inc. ... Johnson and Johnson can be accessed at http://get.Investor-Edge.com/pdf/?c=Johnson%20and%20Johnson&d=26-Feb-2015&s=JNJ ...
Breaking Medicine Technology:Vectorious Medical Technologies Completes $5M Raise 2CSSi's Continued Growth Brings Talented New Hire - Karen Welch Welcomed as Project Manager 2Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 2Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 3Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 4Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 5
... , NEW YORK, ... market research report is available in its catalogue. ... 2009 , http://www.reportlinker.com/p0164742/Global-Markets-for-Assisted-Reproductive-Devices-2009.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire ... U.S., 15 Countries in Europe and Japan. This ...
... Nov. 20 Cyberonics, Inc. (Nasdaq: CYBX ) today announced ... Chief Financial Officer, will present at the 21st Annual Piper Jaffray ... at 12:00 PM EST. The conference session and webcast will ... Piper Jaffray will host a webcast of the presentation live and ...
Cached Medicine Technology:Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2
(Date:2/26/2015)... Kantar Health UK, a leading global ... Best Small Companies to Work For” list for 2015. This ... on the list, which measures employees’ levels of fulfilment, motivation ... Kantar Health UK, and we are delighted to be included ... Mark Hinton-Jones said. “The team is dedicated to putting clients ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 Body Well Therapy, ... ten years of delivering high quality mobile massage ... and other regions across the United States. The company has ... a pivotal year as it sets its sights on additional ... office chair massage services. , “We’ve come a long way ...
(Date:2/26/2015)... 2015 The federal litigation established ... move forward in the U.S. District Court, Eastern ... to court records, the proceeding issued its eighth ... Xarelto Products Liability Litigation, No. 2592) , “The ... and procedures pertaining to the litigation’s Common Benefit ...
(Date:2/26/2015)... 26, 2015 It is no secret that a ... long shown that sleep improves the immune system, allows the body ... even helps a person lose weight. The message is clear, ... Time is crunched and people try to fit more and more ... heavily on the mind and caffeine and alcohol are simply part ...
(Date:2/26/2015)... Since its inception, the Master of ... at University of Western States (UWS) has incorporated innovative ... the two institutions forged a stronger alliance and signed ... between the two institutions, including integration of IFM’s novel ... training for HNFM faculty. As part of the agreement, ...
Breaking Medicine News(10 mins):Health News:Kantar Health UK Named One of The Sunday Times 100 Best Small Companies to Work For 2Health News:Body Well Therapy Celebrates 10 Years of Quality Mobile Massage Services 2Health News:Body Well Therapy Celebrates 10 Years of Quality Mobile Massage Services 3Health News:Federal Xarelto Lawsuits Progress, As Bernstein Liebhard LLP Comments on Issuance of Most Recent Pretrial Order 2Health News:Federal Xarelto Lawsuits Progress, As Bernstein Liebhard LLP Comments on Issuance of Most Recent Pretrial Order 3Health News:The Lodge at Woodloch Launches Rest+Well Blueprint- March 2015 2Health News:The Lodge at Woodloch Launches Rest+Well Blueprint- March 2015 3Health News:The Lodge at Woodloch Launches Rest+Well Blueprint- March 2015 4Health News:The Lodge at Woodloch Launches Rest+Well Blueprint- March 2015 5Health News:The Lodge at Woodloch Launches Rest+Well Blueprint- March 2015 6Health News:UWS and the Institute for Functional Medicine Sign Global Agreement 2
... WEDNESDAY, Feb. 1 (HealthDay News) -- To open a clogged ... metal stent to keep blood flowing or perform surgery. A ... arteries clear for at least two years and help prevent ... [heart] arteries, where re-blockage occurs about 20 percent of the ...
... , WEDNESDAY, Feb. 1 (HealthDay News) -- Sleep apnea, the ... already known to boost the risk of stroke. Now, a ... which there is tissue death in the brain without symptoms. ... loss before a stroke boosts the risk of the stroke ...
... -- Scientists may one day be able to read the minds ... suggests. In their report, published in the Jan. 31 ... California, Berkeley researchers describe how they have found a way to ... person hears in normal conversation. This ability to decode electrical ...
... www.genome.org ) publishes online and in print today ... gained form cutting-edge genomic and epigenomic analyses of ... novel biological insights gained from genomic analyses of ... genomic analyses of breast cancer genes, large scale ...
... , Baltimore, MD -- A new comparison of the ... blockages in the arteries of the neck concludes they ... after treatment with either surgery or a minimally invasive ... remained the same, approximately six percent. Results of the ...
... NBC Sports Group recently teamed up with the National Hockey ... of NHL Hockey"--an informative 10-part video series exploring the science ... students and teachers to use in the classroom, the videos ... standards, and are available to the public cost-free on ...
Cached Medicine News:Health News:Stenting, Surgery Appear Comparable for Opening Neck Artery 2Health News:Sleep Apnea May Be Tied to 'Silent' Strokes, Study Finds 2Health News:Sleep Apnea May Be Tied to 'Silent' Strokes, Study Finds 3Health News:Scientists Use Brain Waves to Eavesdrop on the Mind 2Health News:Genome Research publishes special issue: Cancer Genomics 2Health News:Genome Research publishes special issue: Cancer Genomics 3Health News:Genome Research publishes special issue: Cancer Genomics 4Health News:Genome Research publishes special issue: Cancer Genomics 5Health News:Genome Research publishes special issue: Cancer Genomics 6Health News:Genome Research publishes special issue: Cancer Genomics 7Health News:Stents and surgery for blocked neck arteries are neck-and-neck as lasting stroke prevention 2Health News:Stents and surgery for blocked neck arteries are neck-and-neck as lasting stroke prevention 3Health News:NBC News, NBC Sports and National Science Foundation launch 'Science of NHL Hockey' 2Health News:NBC News, NBC Sports and National Science Foundation launch 'Science of NHL Hockey' 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: